Correlation Between Kymera Therapeutics and HUMANA

Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and HUMANA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and HUMANA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kymera Therapeutics and HUMANA INC, you can compare the effects of market volatilities on Kymera Therapeutics and HUMANA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of HUMANA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and HUMANA.

Diversification Opportunities for Kymera Therapeutics and HUMANA

0.17

Correlation Coefficient

Kymera Therapeutics  HUMANA

Average diversification

The 3 months correlation between Kymera and HUMANA is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and HUMANA INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUMANA INC and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with HUMANA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUMANA INC has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and HUMANA go up and down completely randomly.

Pair Corralation between Kymera Therapeutics and HUMANA

Given the investment horizon of 90 days Kymera Therapeutics is expected to under-perform the HUMANA. In addition to that, Kymera Therapeutics is 2.68 times more volatile than HUMANA INC. It trades about -0.14 of its total potential returns per unit of risk. HUMANA INC is currently generating about 0.03 per unit of volatility. If you would invest  7,961  in HUMANA INC on March 4, 2024 and sell it today you would earn a total of  135.00  from holding HUMANA INC or generate 1.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Kymera Therapeutics  vs.  HUMANA INC

Kymera Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kymera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in July 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

HUMANA INC

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in HUMANA INC are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, HUMANA is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Kymera Therapeutics and HUMANA

The main advantage of trading using opposite Kymera Therapeutics and HUMANA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, HUMANA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUMANA will offset losses from the drop in HUMANA's long position.

The idea behind Kymera Therapeutics and HUMANA INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.